Loading...
Loading...
Pharmaceutical Importer Β· #8 buyer for Heparin Β· $600.0K import value Β· 12 shipments Β· UNITED STATES Β· DGFT Verified
XXSPIXX INX is the #8 importer of Heparin from India with $600.0K in import value and 12 verified shipments. XXSPIXX INX holds a 0.3% market share in Heparin imports based in UNITED STATES. The company sources from 1 verified supplier across 1 formulations shipped to 2 countries.

Verified from 12 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| PFIZER HEALTHCARE INDIA PRIVATE LIMITED | $600.0K | 12 | 100.0% |
XXSPIXX INX sources Heparin from 1 verified Indian supplier based on 12 customs records. The primary supplier is PFIZER HEALTHCARE INDIA PRIVATE LIMITED accounting for 100.0% of imports.
Destination countries from 12 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $300.0K | 6 | 50.0% |
| UNITED STATES OF AMERICA | $300.0K | 6 | 50.0% |
XXSPIXX INX imports Heparin to 2 countries. The primary destination is UNITED STATES receiving 50.0% of shipments worth $300.0K.
| Formulation | Value | Shipments |
|---|---|---|
| HEPARIN 30000U/30ML SSOL 1X25 MDV | $600.0K | 12 |
XXSPIXX INX imports 1 distinct Heparin formulations from India. The top formulation is HEPARIN 30000U/30ML SSOL 1X25 MDV with 12 shipments worth $600.0K.
What XXSPIXX INX and other importers must comply with to import Heparin from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10β18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $68.4M worth of Heparin through 4,586 shipments from 391 suppliers to 137 countries, serving 854 buyers globally. XXSPIXX INX imports $600.0K of this total, accounting for 0.3% of India's Heparin exports with 12 shipments from UNITED STATES. This is verified from 12 customs shipment records covering 1 distinct formulations.
XXSPIXX INX's average Heparin order value is $50.0K per consignment, based on 12 shipments totaling $600.0K. XXSPIXX INX is based in UNITED STATES and ranks #8 among all Heparin importers from India by value. The company sources from 1 verified supplier in India.
XXSPIXX INX sources Heparin from 1 verified Indian supplier: PFIZER HEALTHCARE INDIA PRIVATE LIMITED ($600.0K, 100.0%). This is based on 12 customs records.
XXSPIXX INX ranks #8 among 854 Heparin importers from India with a 0.3% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($19.4M), EVERSANA ($13.4M), BOSTON ONCOLOGY ARABIA ($11.2M). XXSPIXX INX processed 12 shipments from UNITED STATES.
Latest developments and market context
Detailed market intelligence for Heparin β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for XXSPIXX INX's Heparin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
XXSPIXX INX
Company Profile
Multiple products Β· $0 total trade Β· Multiple categories
Verified from customs records
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 854+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for XXSPIXX INX.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Heparin. For current order-level data, contact TransData Nexus.